TUBB4A and prostate carcinoma: These data support that prostate-specific inactivation of both alleles of Tubb4a reduces the malignancy of prostate cancer and alleviates tumor progression and metastasis, which may be involved in regulation of NF-κB and/or β-catenin/c-MYC signaling.